Added to YB: 2025-07-16
Pitch date: 2025-07-14
WST [bullish]
West Pharmaceutical Services, Inc.
+20.52%
current return
Author Info
No bio for this author
Company Info
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Market Cap
$19.5B
Pitch Price
$225.56
Price Target
443.00 (+66%)
Dividend
0.32%
EV/EBITDA
22.44
P/E
40.15
EV/Sales
6.35
Sector
Life Sciences Tools and Services
Category
growth
Is WST the Resilient Healthcare Stock Your Portfolio Needs?
WST: High-quality, wide-moat pharma packaging leader emerging from post-COVID destocking. Strong underlying HVP growth despite 1.9% revenue decline to $2.89B in 2024. Strategically positioned for biologics and GLP-1 markets with $730M CapEx (2023-24). 19.7% operating margin remains above pre-pandemic levels. DCF value $310.50 vs $226 price, 14.5% 5yr IRR. Risk: inventory volatility.
Read full article (18 min)